サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1556846

医薬品卸売・販売の世界市場

Pharmaceuticals Wholesale and Distribution

出版日
ページ情報
英文 276 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
医薬品卸売・販売の世界市場
出版日: 2024年09月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 276 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品卸売・販売の世界市場は2030年までに2兆4,000億米ドルに達する見込み

2023年に1兆5,000億米ドルと推定された医薬品卸売・販売の世界市場は、2030年には2兆4,000億米ドルに達し、分析期間2023-2030年のCAGRは6.8%で成長すると予測されます。本レポートで分析したセグメントの1つであるブランド医薬品卸売流通は、CAGR 5.8%を記録し、分析期間終了時には1兆2,000億米ドルに達すると予測されます。ジェネリック医薬品卸売・流通分野の成長率は、分析期間中CAGR 7.8%と推定されます。

米国市場は推定4,152億米ドル、中国はCAGR 10.7%で成長予測

米国の医薬品卸売・販売市場は、2023年に4,152億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに5,208億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは10.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.0%と6.7%と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

世界の医薬品卸売・販売市場- 主要動向と促進要因のまとめ

医薬品卸売・販売市場はヘルスケアの情勢をどのように形成しているか？

医薬品卸売・販売市場は、医薬品やヘルスケア製品を患者に迅速かつ効率的に届けるために重要な役割を果たしています。この市場には、メーカーから病院、薬局、クリニックなどのヘルスケアプロバイダーへの医薬品の大規模な流通が含まれます。流通ネットワークは、サプライチェーンの完全性を維持するために不可欠であり、製品の有効性を維持するために最適な条件下で保管、取り扱い、配送されることを保証します。この市場の複雑さは、正確な温度管理と取り扱いを必要とする生物製剤やバイオシミラーのような特殊な医薬品の需要の増加に伴い、著しく拡大しています。さらに、オンライン薬局や患者直送モデルの台頭により、従来の流通チャネルが再構築され、卸売業者や販売業者にとって新たな機会と課題が生まれつつあります。

医薬品流通における主な課題と発展とは？

医薬品卸売・販売市場は、規制の遵守、サプライチェーンの安全性、物流・輸送に関連するコストの上昇など、いくつかの課題に直面しています。世界中の規制機関は、医薬品の保管、輸送、流通に厳しいガイドラインを課しており、特に温度の影響を受けやすいものや規制薬物に分類されるものはその傾向が強いです。こうした規制を遵守するには、製品の完全性とトレーサビリティを確保するため、コールドチェーン保管施設や高度な追跡システムなどのインフラに多額の投資を行う必要があります。もう一つの重要な課題は、偽造医薬品の脅威が高まっていることで、そのため、シリアル化や追跡技術など、サプライチェーンのセキュリティ対策が重視されるようになっています。こうした課題にもかかわらず、透明性を高めるためのブロックチェーンの利用や、効率改善とエラー削減のための倉庫・配送センターにおける自動化の導入など、技術の進歩によって市場は進化しています。

テクノロジーは医薬品流通市場をどう変革するか？

テクノロジーは医薬品卸売・販売市場において変革的な役割を果たしており、効率化を推進し、サプライチェーンの可視性を向上させています。最も重要な動向の1つは、サプライチェーン全体で医薬品のリアルタイム追跡を可能にするデジタルプラットフォームの採用です。これらのプラットフォームは、IoT（モノのインターネット）センサーやRFID（無線自動識別）タグなどの技術を活用して、輸送中の製品の状態を監視し、温度に敏感な医薬品が必要な温度範囲内に維持されるようにします。もうひとつの大きなイノベーションは、ブロックチェーン技術の活用によるサプライチェーンの透明性とトレーサビリティの向上で、偽造医薬品のリスクを低減し、規制要件の遵守を確実にしています。また、倉庫や配送センターでは、作業の合理化、人件費の削減、注文の正確性の向上のために、自動化やロボット化がますます進んでいます。このような技術的進歩は、品質と安全性を最高水準に維持しながら、より迅速で確実な医薬品配送を求める流通業者の高まる需要に応えるのに役立っています。

医薬品卸売・販売市場の成長促進要因は？

医薬品卸売・販売市場の成長は、いくつかの重要な要因によってもたらされます。主な原動力のひとつは、世界人口の高齢化、慢性疾患の増加、先進的な治療法の利用可能性の高まりによる医薬品需要の増加です。この需要により、製品を効率的かつ確実に配送する流通網へのプレッシャーが高まっています。もう一つの大きな促進要因は、特にヘルスケアへのアクセスが改善し、医薬品需要が高まっている新興国での世界の医薬品市場の拡大です。さらに、個別化医療へのシフトや、専門的な取り扱いと流通を必要とする生物製剤やバイオシミラーの普及が、より高度な流通ネットワークの必要性を高めています。デジタル・プラットフォームや自動化などの技術導入の増加も、業務効率の向上とコスト削減によって市場の成長に寄与しています。これらの要因は、製薬業界の世界化の進行と相まって、医薬品卸売・販売市場の成長を今後数年間維持すると予想されます。

調査対象企業の例（全42件）

  • A.F. Hauser Pharmaceutical Inc.
  • AAH Pharmaceuticals Ltd.
  • Alfresa Holdings Corporation
  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • China Resources Pharmaceutical Group
  • Dakota Drug, Inc.
  • Mawdsley-Brooks & Co
  • McKesson Corporation
  • Medipal Holdings Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP27269

Global Pharmaceuticals Wholesale and Distribution Market to Reach US$2.4 Trillion by 2030

The global market for Pharmaceuticals Wholesale and Distribution estimated at US$1.5 Trillion in the year 2023, is expected to reach US$2.4 Trillion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Branded Drugs Wholesale and Distribution, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.2 Trillion by the end of the analysis period. Growth in the Generic Drugs Wholesale and Distribution segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$415.2 Billion While China is Forecast to Grow at 10.7% CAGR

The Pharmaceuticals Wholesale and Distribution market in the U.S. is estimated at US$415.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$520.8 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Pharmaceuticals Wholesale and Distribution Market - Key Trends & Drivers Summarized

How Is the Pharmaceuticals Wholesale and Distribution Market Shaping the Healthcare Landscape?

The pharmaceuticals wholesale and distribution market plays a crucial role in ensuring that medicines and healthcare products reach patients promptly and efficiently. This market encompasses the large-scale distribution of pharmaceutical products from manufacturers to healthcare providers, including hospitals, pharmacies, and clinics. The distribution network is vital for maintaining the supply chain integrity, ensuring that products are stored, handled, and delivered under optimal conditions to preserve their efficacy. The complexity of this market has grown significantly with the increasing demand for specialized medications, such as biologics and biosimilars, which require precise temperature control and handling. Additionally, the rise of online pharmacies and direct-to-patient delivery models is reshaping traditional distribution channels, creating new opportunities and challenges for wholesalers and distributors.

What Are the Key Challenges and Developments in Pharmaceuticals Distribution?

The pharmaceuticals wholesale and distribution market faces several challenges, including regulatory compliance, supply chain security, and the rising costs associated with logistics and transportation. Regulatory bodies across the globe impose strict guidelines on the storage, transportation, and distribution of pharmaceutical products, particularly those that are temperature-sensitive or classified as controlled substances. Compliance with these regulations requires significant investment in infrastructure, such as cold chain storage facilities and advanced tracking systems, to ensure product integrity and traceability. Another critical challenge is the growing threat of counterfeit drugs, which has led to increased emphasis on supply chain security measures, including serialization and track-and-trace technologies. Despite these challenges, the market is evolving with advancements in technology, such as the use of blockchain for enhanced transparency and the adoption of automation in warehousing and distribution centers to improve efficiency and reduce errors.

How Is Technology Transforming the Pharmaceuticals Distribution Market?

Technology is playing a transformative role in the pharmaceuticals wholesale and distribution market, driving efficiency and improving supply chain visibility. One of the most significant trends is the adoption of digital platforms that enable real-time tracking of pharmaceutical products throughout the supply chain. These platforms leverage technologies such as IoT (Internet of Things) sensors and RFID (Radio Frequency Identification) tags to monitor the condition of products during transit, ensuring that temperature-sensitive medications are maintained within the required temperature range. Another major innovation is the use of blockchain technology to enhance transparency and traceability in the supply chain, reducing the risk of counterfeit drugs and ensuring compliance with regulatory requirements. Automation and robotics are also increasingly being used in warehouses and distribution centers to streamline operations, reduce labor costs, and improve order accuracy. These technological advancements are helping distributors to meet the growing demand for faster, more reliable delivery of pharmaceuticals while maintaining the highest standards of quality and safety.

What Are the Growth Drivers for the Pharmaceuticals Wholesale and Distribution Market?

The growth in the pharmaceuticals wholesale and distribution market is driven by several key factors. One of the primary drivers is the increasing demand for pharmaceutical products, driven by the aging global population, the rise in chronic diseases, and the growing availability of advanced therapies. This demand is placing greater pressure on the distribution network to deliver products efficiently and reliably. Another significant driver is the expansion of the global pharmaceutical market, particularly in emerging economies where access to healthcare is improving, and the demand for medications is rising. Additionally, the shift towards personalized medicine and the growing prevalence of biologics and biosimilars, which require specialized handling and distribution, are driving the need for more sophisticated distribution networks. The increasing adoption of technology, such as digital platforms and automation, is also contributing to market growth by improving operational efficiency and reducing costs. These factors, combined with the ongoing globalization of the pharmaceutical industry, are expected to sustain the growth of the pharmaceuticals wholesale and distribution market in the coming years.

Select Competitors (Total 42 Featured) -

  • A.F. Hauser Pharmaceutical Inc.
  • AAH Pharmaceuticals Ltd.
  • Alfresa Holdings Corporation
  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • China Resources Pharmaceutical Group
  • Dakota Drug, Inc.
  • Mawdsley-Brooks & Co
  • McKesson Corporation
  • Medipal Holdings Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Pharmaceuticals Wholesale and Distribution - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Complexity of Specialty Drugs Strengthens Business Case for Enhanced Distribution Networks
    • Rise of E-commerce and Direct-to-Patient Models Drive Transformation in Pharmaceuticals Distribution
    • Cold Chain Logistics Generates Demand for Specialized Distribution Services
    • Data Analytics and AI Adoption Drives Operational Efficiency in Pharmaceuticals Wholesale
    • Growing Emphasis on Traceability Expands Addressable Market for Advanced Tracking Solutions
    • Shift Toward Personalized Medicine Spurs Innovation in Pharmaceuticals Distribution
    • Sustainability Initiatives Drive Demand for Eco-Friendly Packaging and Distribution Solutions
    • Pharmaceutical Counterfeiting Issues Create Opportunities for Secure Distribution Channels
    • Rising Demand for Biosimilars Sustains Growth in Specialized Distribution Services
    • Emerging Markets Fuel Expansion Opportunities for Pharmaceuticals Distributors
    • Digitalization and Cloud-Based Solutions Impact on Distribution Efficiency
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pharmaceuticals Wholesale and Distribution Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pharmaceuticals Wholesale and Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Branded Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Branded Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Branded Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Generic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Generic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Generic Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Pharmaceuticals Wholesale and Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Pharmaceuticals Wholesale and Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Pharmaceuticals Wholesale and Distribution by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Pharmaceuticals Wholesale and Distribution by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Pharmaceuticals Wholesale and Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Pharmaceuticals Wholesale and Distribution by Type - Branded Drugs and Generic Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by Type - Percentage Breakdown of Value Revenues for Branded Drugs and Generic Drugs for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Pharmaceuticals Wholesale and Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Pharmaceuticals Wholesale and Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION